Funding Details
- Awarder
- StartEngine
- Date Award
- July 02, 2023
- Vertical
- Biopharma
- Funding URL
- View Funding Page
- Premoney Valuation
-
$25,000,000
- Valuation
-
$25,000,000,000,000
Company Info
- Founding Year
- Not provided
- Traction
- None
- Organizations Involved
- None
- Founders
- Urban Austin Kiernan, Stephen Adam Munk, David F Hendren
- Company Description
- iMetabolic Biopharma Corporation (iMBP) is an early-stage drug discovery company innovating at the intersection of technology and biotechnology to develop new, life-saving drugs to fight against some of today's most devastating chronic diseases affecting our loved ones. Currently, we are pre-market, advancing five different disease asset programs, and in the process of developing a proprietary technological platform for the discovery of more effective and less expensive drugs. This will allow us to continuously expand our drug pipeline while increasing company value.
- Market
- Healthcare
- Location
-
Tempe,
AZ,
US
- Coinvestors
- None
Links